SON becomes the sponsor of the Master Innovative Drugs for the 2024-2025 academic year. SON is immensely proud to announce its role as the sponsor of the Master Innovative Drugs, a pioneering program in pharmaceutical sciences. At SON, education and knowledge transfer have always been at the core of our mission. This new collaboration aligns […]
SON becomes the sponsor of the Master Innovative Drugs
SON will be attending CPHI 2024 in Milan. Every year for the past 35 years, CPHI has brought together thought leaders, innovators, and pioneers in the pharmaceutical industry. Join SON to explore its functionalized nanomaterials, nanocatalysts, and gold nanoparticles at BOOTH 6 SU 100. Meet SON at CPHI 2024 We are excited to announce that […]
SON will be present at CPHI in Milan from October 8 to 10, 2024
A New Therapeutic Approach Some cancer patients can now benefit from a new therapeutic approach: theranostics. But what exactly is it? This technique combines both the diagnosis and treatment of tumors, offering an integrated and targeted approach. This method allows not only the identification of tumors via imaging but also their direct treatment. It represents […]
Theranostics: a revolution in cancer treatment